A novel HDAC inhibitor chidamide combined with imatinib synergistically targets tyrosine kinase inhibitor resistant chronic myeloid leukemia cells
- Resource Type
- Article
- Source
- In
Biomedicine & Pharmacotherapy September 2020 129 - Subject
- Language
- ISSN
- 0753-3322